Blackstone invests $2 bln in Alnylam Pharma
12 Apr Blackstone invests $2 bln in Alnylam Pharma
Posted at 11:41h
in
News
by KMFSLLP
Blackstone Group Inc said on
Monday it invested $2 billion in Alnylam Pharmaceuticals Inc
through an equity-and-debt deal, giving the drugmaker a
financial boost to develop its experimental therapies.
![](http://feeds.feedburner.com/~r/reuters/UKBankingFinancial/~4/ooKawCOADKk)
Sorry, the comment form is closed at this time.